A review of the cost-effectiveness of interventions to prevent sexual transmission of HIV in the United States

被引：1

作者：

Pinkerton S.D. ^{[1
,2
]}

Johnson-Masotti A.P. ^{[1
]}

Holtgrave D.R. ^{[2
]}

Farnham P.G. ^{[2
,3
]}

机构：

[1] Center for AIDS Intervention Research, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee, WI

[2] Division of HIV/AIDS Prevention: Intervention Research and Support, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA

[3] Department of Economics, Georgia State University, Atlanta, GA

来源：

AIDS and Behavior | 2002年 / 6卷 / 1期

关键词：

Cost-effectiveness; Economic analysis; Human immunodeficiency virus; Prevention;

D O I：

10.1023/A:1014572427706

中图分类号：

学科分类号：

摘要：

Because resources to fund HIV prevention are limited, public health decision makers - such as health departments and HIV prevention community planning groups - need to know which prevention strategies are the most cost-effective. In the past several years, a number of studies have appeared in the literature that assess the cost-effectiveness of interventions to prevent the sexual transmission of HIV in the United States. Here, we comprehensively review 16 such studies and then outline an agenda for further research to advance the cost-effectiveness literature and to make the findings of these studies more useful for public health decision makers. The research summarized here provides compelling evidence that interventions to prevent sexual transmission of HIV can be highly cost-effective. Small-group, community-level, and outreach-based sexual risk reduction interventions, in particular, appear to be very efficient strategies for preventing the spread of HIV in moderate- to high-risk populations.

引用

页码：15 / 31

页数：16

共 91 条

[1]

Allard R., A family of mathematical models to describe the risk of infection by a sexually transmitted agent, Epidemiology, 1, pp. 30-33, (1990)

[2]

Allard R., A mathematical model to describe the risk of infection from sharing injection equipment, Journal of Acquired Immune Deficiency Syndromes, 3, pp. 1010-1016, (1990)

[3]

Bedimo A.L., Pinkerton S.D., Cohen D.A., Gray B., Farley T.A., Cost-savings of a condom social marketing program, International Journal of STD and AIDS

[4]

Brandeau M.L., Owens D.K., Sox C.H., Wachter R.M., Screening women of childbearing age for human immunodeficiency virus: A model-based policy analysis, Management Science, 39, pp. 72-92, (1993)

[5]

Brown B.S., Beschner G.M., Handbook of Risk of AIDS: Injection Drug Users and Sexual Partners, (1993)

[6]

Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood - France, United Kingdom, and United States, January 1988-August 1994, Morbidity and Mortality Weekly Report, 44, pp. 929-933, (1995)

[7]

HIV/AIDS Surveillance Report, 11, pp. 1-44, (1999)

[8]

Choi K.H., Coates T.J., Prevention of HIV infection, AIDS, 8, pp. 1371-1389, (1994)

[9]

Cohen D.A., Farley T.A., Bedimo-Etame J.R., Scribner R., Ward W., Kendall C., Rice J., Implementation of a condom social marketing program in Louisiana, 1993 to 1996, American Journal of Public Health, 89, pp. 204-208, (1999)

[10]

Coyle S.L., Needle R.H., Normand J., Outreach-based HIV prevention for injecting drug users: A review of published outcome data, Public Health Reports, 113, SUPPL. 1, pp. 19-30, (1998)

← 1 2 3 4 5 6 7 8 9 10 →